BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today ...
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. (OSUR), please note that the first sentence of the ...
GAITHERSBURG, Md. -- An FDA advisory committee has voted 17-0 to recommend approval for the OraQuick In-Home HIV Test. If approved, it will be the first over-the-counter home HIV test. About 2.8 ...
Competitor sues OraSure of Bethlehem in federal court over OraQuick product. BETHLEHEM – The crowning achievement of OraSure Technologies is under attack by a rival rapid HIV test company. Inverness ...
Impaired antibody response in an AIDS patient compromised the accuracy of the test. The OraQuick Advance Rapid HIV-1 Antibody Test has transformed HIV testing from a cumbersome process to a rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results